CHPA elects board of directors
AMELIA ISLAND, Fla. — Members of the board of directors of the Consumer Healthcare Products Association on Wednesday were elected at the association’s Annual Executive Conference. James Mackey, SVP U.S. Region Head, Merck Consumer Care, will continue to serve as chair for a second term.
“CHPA is looking forward to another successful year under the vision and leadership of our chair Jim Mackey,” CHPA President and CEO Scott Melville stated. “We welcome our new members and thank all of our board members for serving an integral role in shaping the future of the industry.”
Newly elected CHPA board members include:
- Daniel Chiazza, SVP Nielsen Consumer Insights, North America, Nielsen;
- Jeffrey Cohen, VP and general manager, Meda Consumer Healthcare;
- Jeffery Gerchenson, chairman and CEP, Alva-Amco Pharmacal Companies;
- Thomas Higgins, president, North America, Pfizer Consumer Healthcare;
- Alexander Lacik, SVP NA, Reckitt Benckiser; and
- Ryan Olohan, industry director for healthcare, U.S. Sales, Google.
Poll: Majority of Americans satisfied with healthcare system as it stands
PRINCETON, N.J. — Two-thirds of Americans are satisfied with the way the healthcare system is working for them today, according to a Gallup poll released earlier this week. While health insurance status was a major determinant of this satisfaction, even one-third of those who didn’t have health insurance still reported they were satisfied.
Those seniors eligible for Medicare were the most satisfied, followed by younger Americans who are less likely to have health insurance and less likely to have chronic disease in need of management.
"Most Americans do not believe the healthcare system in this country is in crisis," the Gallup poll concluded. "At the same time, a clear majority of Americans now say they disapprove of the Affordable Care Act. Their disapproval could be because many don’t see the need to change the system, and worry that the new legislation will affect a process they currently are satisfied with."
Study: Probiotic supplementation reduces pediatric doctor visits
NEW YORK — A study published earlier this week in the journal Pediatrics determined that the probiotic Lactobacillus reuteri helped substantially reduce episodes of diarrhea and respiratory tract infections among children in a daycare setting.
Additionally, the number of doctor visits, antibiotic use, absenteeism from day school and parental absenteeism from work were significantly reduced in the L. reuteri group.
A cost-benefit analysis revealed significant reductions in costs in the L. reuteri-treated children, researchers noted. No adverse events related to the study product were reported.